Investigators Hope Oregovomab Combo Will Show Benefit in Advanced Epithelial Ovarian Cancer
May 19, 2022 9:07 amby Lindsay Fischer
A new murine monoclonal antibody B43.12 is under investigation in combination with paclitaxel and carboplatin as a treatment option for patients with advanced epithelial ovarian cancer.
Oregovomab (Ovarex) in combination with paclitaxel and carboplatin for patients with